相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Circulating levels of inflammatory cytokines and risk of colorectal adenomas
Sangmi Kim et al.
CANCER RESEARCH (2008)
Plasminogen activator inhibitor-1 (Pai-1) blockers suppress intestinal polyp formation in Min mice
Michihiro Mutoh et al.
CARCINOGENESIS (2008)
Visceral fat: A key mediator of steatohepatitis in metabolic liver disease
David van der Poorten et al.
HEPATOLOGY (2008)
Association between BMI and metabolic syndrome and adenomatous colonic polyps in Korean men
Go-Eun Lee et al.
OBESITY (2008)
Is metabolic syndrome a risk factor for colorectal adenoma?
Jeong Hwan Kim et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)
The metabolic syndrome and risk of incident colorectal cancer
Rehana L. Ahmed et al.
CANCER (2006)
Tobacco smoking and colorectal hyperplastic and adenomatous polyps
Bu-Tian Ji et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2006)
NAFLD, obesity, and bariatric surgery
Paul Angulo
GASTROENTEROLOGY (2006)
Paradoxical roles of the immune system during cancer development
KE de Visser et al.
NATURE REVIEWS CANCER (2006)
Increasing incidence of colorectal cancer in Asia: implications for screening
JJY Sung et al.
LANCET ONCOLOGY (2005)
Diagnosis and management of the metabolic syndrome - An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement
SM Grundy et al.
CIRCULATION (2005)
Non-alcoholic hepatic steatosis and its relation to increased plasma biomarkers of inflammation and endothelial dysfunction in non-diabetic men. Role of visceral adipose tissue
G Targher et al.
DIABETIC MEDICINE (2005)
Prevalence of non-alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults
S Jimba et al.
DIABETIC MEDICINE (2005)
Global cancer statistics, 2002
DM Parkin et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2005)
Smoldering and polarized inflammation in the initiation and promotion of malignant disease
F Balkwill et al.
CANCER CELL (2005)
Increased prevalence of fatty liver in arterial hypertensive patients with normal liver enzymes: role of insulin resistance
G Donati et al.
GUT (2004)
Increase in the prevalence of fatty liver in Japan over the past 12 years: analysis of clinical background
S Kojima et al.
JOURNAL OF GASTROENTEROLOGY (2003)
Daily soluble aspirin and prevention of colorectal adenoma recurrence: One-year results of the APACC trial
R Benamouzig et al.
GASTROENTEROLOGY (2003)
Non-steroidal anti-inflammatory drug use is associated with reduction in recurrence of advanced and non-advanced colorectal adenomas (United States)
JA Tangrea et al.
CANCER CAUSES & CONTROL (2003)
Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference
BA Neuschwander-Tetri et al.
HEPATOLOGY (2003)
A randomized trial of aspirin to prevent colorectal adenomas
JA Baron et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
The utility of radiological imaging in nonalcoholic fatty liver disease
S Saadeh et al.
GASTROENTEROLOGY (2002)
The colorectal adenoma-carcinoma sequence
A Leslie et al.
BRITISH JOURNAL OF SURGERY (2002)
Nonalcoholic fatty liver disease - A feature of the metabolic syndrome
G Marchesini et al.
DIABETES (2001)
Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
JI Cleeman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Body mass index and colon cancer mortality in a large prospective study
TK Murphy et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2000)
Fatty infiltration of liver in hyperlipidemic patients
N Assy et al.
DIGESTIVE DISEASES AND SCIENCES (2000)
分享论文
